PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsperiodontal diseases
MeSH D010510 - periodontal diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009059:Mouth diseases
$
Success rate
D010510: 
Periodontal diseases
$
Success rate
D005882:Gingival diseases
0 Companies
0 Drugs
Success rate
D010483:Periapical diseases
0 Companies
0 Drugs
Success rate
D010509:Periodontal cyst
0 Companies
0 Drugs
Success rate
D010518:Periodontitis
0 Companies
0 Drugs
Success rate
D014085:Tooth migration
0 Companies
0 Drugs
Success rate
D014086:Tooth mobility
0 Companies
0 Drugs
Success rate
D016388:Tooth loss
0 Companies
0 Drugs
Success rate
D017823:Furcation defects
0 Companies
0 Drugs
Success rate
D055093:Periodontal atrophy
0 Companies
0 Drugs
Success rate
D057873:Peri-implantitis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Johnson & JohnsonChlorhexidine Microderm  1991-04-15   
Chlorhexidine Prevacare  1992-01-28   
3MChlorhexidine Avagard  2001-06-07   
Chlorhexidine Peridex  1986-08-13   
Chlorhexidine Soluprep 2029-07-26 2018-08-08   
Xttrium LaboratoriesChlorhexidine Chlorhexidine  2009-06-18   
Chlorhexidine Exidine  1984-12-24   
AkornChlorhexidine Chlorhexidine  1996-05-07   
Sage TherapeuticsChlorhexidine Chlorhexidine 2023-05-12 2005-04-25   
Medline IndustriesChlorhexidine Readyprep Chg  2018-11-20   
PAI PharmaChlorhexidine Chlorhexidine  1995-12-15   
Lyne LaboratoriesChlorhexidine Chlorhexidine  1995-12-28   
Dexcel PharmaChlorhexidine Periochip  1998-05-15   
Colgate-PalmoliveChlorhexidine Periogard  1994-01-14   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
17%
1/6
Phase 2
73%
8/11
Phase 3
80%
8/10
Approved: 1Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Johnson & Johnson
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use